VIRAL SUPPRESSION AT WEEK 4 EXCEEDS THE IL28B SNP FOR PREDICTING SVR IN PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY OF GENOTYPE 1 INFECTED PATIENTS WITH CHRONIC HEPATITIS C

被引：0

作者：

Oze, Tsugiko ^{[1
]}

Hiramatsu, Naoki ^{[1
]}

Yakushijin, Takayuki ^{[1
]}

Doi, Yoshinori ^{[2
]}

Ogawa, Hiroyuki ^{[3
]}

Hagiwara, Hideki ^{[4
]}

Mita, Eiji ^{[5
]}

Kaneko, Akira ^{[6
]}

Katayama, Kazuhiro ^{[7
]}

Hijioka, Taizo ^{[8
]}

Tamura, Shinji ^{[9
]}

Yoshihara, Harumasa ^{[10
]}

Inoue, Atsuo ^{[11
]}

Imai, Yasuharu ^{[12
]}

Hayashi, Eijirou ^{[13
]}

Hosui, Atsushi ^{[1
]}

Miyagi, Takuya ^{[1
]}

Yoshida, Yuichi ^{[1
]}

Tatsumi, Tomohide ^{[1
]}

Kiso, Shinichi ^{[1
]}

Kanto, Tatsuya ^{[1
]}

Kasahara, Akinori ^{[1
]}

Hayashi, Norio ^{[4
]}

Takehara, Tetsuo ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan

[2] Otemae Hosp, Osaka, Japan

[3] Nishinomiya Municipal Cent Hosp, Nishinomiya, Hyogo, Japan

[4] Kansai Rousai Hosp, Amagasaki, Hyogo, Japan

[5] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan

[6] NTT W Osaka Hosp, Osaka, Japan

[7] Natl Hosp Org Osaka Minami Med Ctr, Kawachi Nagano, Japan

[8] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan

[9] Minoh City Hosp, Mino, Japan

[10] Osaka Rosai Hosp, Sakai, Osaka, Japan

[11] Osaka Gen Med Ctr, Osaka, Japan

[12] Ikeda Municipal Hosp, Ikeda, Osaka, Japan

[13] Mutual Aid Assoc Publ Sch Teacher, Kinki Cent Hosp, Itami, Hyogo, Japan

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：852A / 853A

页数：2

共 50 条

[41] IL28B polymorphism and virological responseduring 12 weeks of pegylated interferon and ribavirin treatment in Polish chronic hepatitis C patients
Swiatek, B.
Januszkiewicz, D.
Rembowska, J.
Bereszynska, I.
Kowala-Piaskowska, A.
Mozer-Lisewska, I.
Wysocki, J.
Nowak, J.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 313 - 313
[42] Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1
Sharafi, Heidar
Alavian, Seyed Moayed
Keshvari, Maryam
HEPATITIS MONTHLY, 2015, 15 (01) : 1 - 5
[43] Therapy with pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.
Romero, M
Nunez, M
Perez-Olmeda, M
Gonzalez, J
Castro, A
Arribas, JR
Barreiro, P
Soriano, V
Garcia-Samaniego, J
HEPATOLOGY, 2002, 36 (04) : 363A - 363A
[44] THE EFFECTS OF IL28B AND ITPA GENOTYPES ON ANTIVIRAL RESPONSE AND HEMOLYTIC ANEMIA IN HCV GENOTYPE 1 PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY
Choi, J.
Kim, H.
Park, S.
Oh, M.
Jung, E.
Lee, Y.
Shin, J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S25 - S25
[45] Muscle adiposity influences viral response to pegylated interferon plus ribavirin treatment in patients with genotype 1 chronic hepatitis C
Okada, Michiaki
Mizuta, Toshihiko
Kitajima, Yoichiro
Kawaguchi, Yasunori
Iwane, Shinji
Ide, Yasushi
Eguchi, Yuichiro
Anzai, Keizo
Ozaki, Iwata
HEPATOLOGY, 2013, 58 : 1152A - 1152A
[46] Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads
Kohno, Hiroshi
Kouno, Hirotaka
Aimitsu, Shiomi
Aisaka, Yasuyuki
Kitamoto, Mikiya
Kawakami, Hiroiku
Chayama, Kazuaki
HEPATOLOGY RESEARCH, 2011, 41 (07) : 626 - 634
[47] IL28B rs12979860 CC Genotype, Metabolic Profile and SVR in Patients with Genotype 1 Chronic Hepatitis C
Petta, Salvatore
Rosso, Chiara
Leung, Reynold C.
Abate, Maria Lorena
Booth, David
Salamone, Federico
Gambino, Roberto
Rizzetto, Mario
Caviglia, Gian Paolo
Smedile, Antonina
Grimaudo, Stefania
Camma, Calogero
Craxi, Antonio
George, Jacob
Bugianesi, Elisabetta
HEPATOLOGY, 2012, 56 : 683A - 683A
[48] IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin
Rallon, Norma I.
Soriano, Vincent
Naggie, Susanna
Restrepo, Clara
Goldstein, David
Vispo, Eugenia
McHutchison, John
Benito, Jose M.
AIDS, 2011, 25 (08) : 1025 - 1033
[49] AN IL28B GENOTYPE-BASED MODEL FOR PERSONALIZED PREDICTION OF RESPONSE TO PEGYLATED-INTERFERON-ALFA AND RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C
O'Brien, Thomas R.
Everhart, James E.
Chung, Raymond T.
Morgan, Timothy R.
Bonkovsky, Herbert L.
Shao, Yongwu
Lok, Anna S.
Shiffman, Mitchell L.
Sninsky, John
Pfeiffer, Ruth
HEPATOLOGY, 2010, 52 (04) : 382A - 382A
[50] Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy
Sood, Ajit
Midha, Vandana
Goyal, Omesh
ANNALS OF HEPATOLOGY, 2014, 13 (05) : 503 - 509

← 1 2 3 4 5 →